Current concepts for the use of platelet-rich plasma in the foot and ankle

Clin Podiatr Med Surg. 2011 Jan;28(1):155-70. doi: 10.1016/j.cpm.2010.09.001.

Abstract

Platelet-rich plasma (PRP) injections have been used and studied since the 1970s. Its use has become more popularized over the last several years in the treatment of foot and ankle injuries. Platelets are a normal product found in the clotting cascade and inflammatory process of healing. They produce granules that release growth factors that promote healing. PRP works by increasing the concentration of platelets, thereby increasing the concentration of growth factors and increasing healing potential. PRP has an advantage over many tissue engineering products in that it is autologous. It has been studied and used for the treatment of tendon injuries, chronic wounds, ligamentous injuries, cartilage injuries, muscle injuries, and bone augmentation. The results from in vitro and in vivo studies in foot and ankle injuries are promising. The applications for treatment in the foot and ankle may be broader than once thought.

Publication types

  • Review

MeSH terms

  • Achilles Tendon / injuries*
  • Achilles Tendon / physiopathology
  • Ankle Injuries / complications
  • Ankle Injuries / diagnosis
  • Ankle Injuries / therapy*
  • Biological Products / therapeutic use*
  • Fasciitis, Plantar / etiology
  • Fasciitis, Plantar / physiopathology
  • Fasciitis, Plantar / therapy
  • Female
  • Follow-Up Studies
  • Foot Injuries / complications
  • Foot Injuries / diagnosis
  • Foot Injuries / therapy*
  • Humans
  • Male
  • Platelet-Rich Plasma*
  • Risk Assessment
  • Severity of Illness Index
  • Tendinopathy / etiology
  • Tendinopathy / physiopathology
  • Tendinopathy / therapy
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Biological Products